Kernodle & Katon Asset Management Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$1.63M Buy
13,080
+220
+2% +$26.3K 0.98% 23
2016
Q4
$1.48M Buy
12,860
+1,497
+13% +$173K 0.89% 35
2016
Q3
$1.34M Buy
11,363
+1,520
+15% +$184K 0.83% 31
2016
Q2
$1.19M Buy
9,843
+4,534
+85% +$515K 1.1% 17
2016
Q1
$574K Buy
5,309
+3,692
+228% +$382K 0.54% 19
2015
Q4
$166K Buy
+1,617
New +$163K 0.16% 32

Other funds holding JNJ

Kernodle & Katon Asset Management Group's JNJ Position: Q1 2017 in Review

Kernodle & Katon Asset Management Group increased its Johnson & Johnson (JNJ) stake by 1.7% in Q1 2017, buying an estimated $26.3K and bringing the position to 13,080 shares worth $1.63M. The position accounts for 0.98% of the portfolio, ranked #23.

Kernodle & Katon Asset Management Group first reported a position in JNJ in Q4 2015 and has held it in 6 quarters since. 2,349 funds tracked by Wall St. Rank hold JNJ as of Q1 2017.

  • Kernodle & Katon Asset Management Group held 13,080 shares of Johnson & Johnson worth $1.63M as of Q1 2017.
  • Kernodle & Katon Asset Management Group bought 220 Johnson & Johnson shares in Q1 2017, an estimated $26.3K.
  • Johnson & Johnson made up 0.98% of Kernodle & Katon Asset Management Group's portfolio in Q1 2017, its #23 holding.
  • Kernodle & Katon Asset Management Group first reported a position in Johnson & Johnson in Q4 2015 and has held it in 6 quarters since.
  • 2,349 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2017.

Based on Kernodle & Katon Asset Management Group's 13F filing for Q1 2017, filed 12 May 2017.